Attached files
| file | filename |
|---|---|
| EX-3 - RXBIDS 8-K JANUARY 18, 2011 - EXHIBIT 3 - RxBids | rxbids8kjan18exh3.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 18, 2011
RxBids
(Exact Name of registrant as specified in Its charter)
|
Nevada
|
|
000-53373
|
|
20-1226081
|
|
(State or Other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
9050 W. Warm Springs Rd. #12-2129
Las Vegas, Nevada
|
|
89148
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(702) 540-2222
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On January 18, 2011, the Board of Directors of RxBids, a Nevada corporation (the “Company”), held a special meeting, at which the Company’s two incumbent directors, Mack Bradley and Todd Albiston, unanimously resolved to amend Article 3.02 of the Company’s Bylaws to provide for a minimum of two directors.
(d) Exhibits
Exhibit No. Description of Exhibit
3 Text of amendment to Bylaws
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
RxBids
|
||
|
Dated: January 24, 2011
|
By:
|
/s/ Mack Bradley
|
|
Name: Mack Bradley
|
||
|
Title: President and CEO
|
||
2